Gefen Megurim: How Much Of The Balance-Sheet Jump Is Accounting And How Much Is Execution

The main article focused on whether Gefen's enlarged pipeline can actually move through permits, capital and profit-recognition timing. This follow-up isolates an earlier question: what exactly entered the balance sheet on the day the Abu transaction closed, and how much of that jump already reflects economic execution versus accounting measurement.

This is not a technical footnote. 2025 ended with a much larger balance sheet, much higher equity and a sharp jump in land inventory. But inside those numbers sit purchase-price allocation, fair-value measurement of non-controlling interests, excess value assigned to a project pipeline and discounted related-party debt. That is the core distinction. The value may be there, but a large part of it still has to travel through permits, signatures, financing and profit extraction before it becomes value that ordinary shareholders can truly access.

What Actually Jumped On The Balance Sheet

Anyone opening the balance sheet and seeing it expand from NIS 102.3 million to NIS 264.3 million sees a real change in scale. But the composition of that change tells a different story. Land inventory jumped to NIS 214.5 million from NIS 51.7 million, long-term related-party liabilities rose to NIS 37.8 million from NIS 0.5 million, goodwill of NIS 6.5 million appeared from zero, and total equity rose to NIS 145.2 million from NIS 54.5 million.

That is a genuine balance-sheet expansion, but not one driven by completed projects, realized profit or customer cash. It was created on the closing date, when the company brought newly measured assets and liabilities into the accounts at fair value. That distinction matters. For shareholders, a larger balance sheet does not automatically mean that the pipeline has already converted into earnings and cash.

NIS 97 Million Of Business Combination Cost Is Not The Same As NIS 97 Million Paid To Abu

The immediate closing report and note 16 make the clearest consideration component explicit: Gefen issued 107,458,221 shares to Abu, and note 16 measures their fair value at NIS 82.85 million based on the December 29, 2025 closing price. But the PPA does not stop there. The allocation adds NIS 14.19 million of fair-valued non-controlling interests in the Uriya Hachiti and Harei Golan projects, lifting total business-combination cost to NIS 97.04 million.

This is exactly where a quick read can go wrong. The NIS 97.04 million figure is not simply "more shares handed to Abu." It includes a valuation layer created by IFRS measurement of non-controlling interests at fair value on the acquisition date. In other words, the accounting figure that reshapes the balance sheet is larger than the direct share consideration Abu received.

On the other side of the equation, the company recognized NIS 90.53 million of net identifiable assets and NIS 6.51 million of goodwill. That is also important. The goodwill here is not huge, and the note says it is not expected to be tax deductible. So the debate is not really about paying up for an enormous synergy story. It is about how much of the identifiable fair-value uplift can ultimately mature into execution.

Most Of The Imported Value Sits In A Discounted Project Pipeline

This is the key line in the whole exercise. The PPA assigns NIS 110.762 million of excess value to the project pipeline. That is by far the largest component, well above the NIS 1.832 million excess value created by discounting the owner loan and well above the NIS 6.509 million of goodwill. So the balance-sheet jump did not mainly come from an operating asset already producing, or from inventory already proven through sales. It came from translating future project-level shareholder cash flows into present value.

The valuation file is explicit about how that number is built. Expected shareholder cash flows were discounted using a weighted discount rate of about 12%, with status-based discount rates ranging from 9.5% for projects already in execution to 14.5% for projects that are still only in planning without an approved plan, alongside certainty factors ranging from 100% to 0%. That is not a criticism of the method. It is the method. But the investor implication is clear: a meaningful part of the value imported into the balance sheet is discounted value of what still has to happen, not value from what has already happened.

Only two projects carry the bulk of the excess value inside the high-certainty, permit-submitted bucket: Pladot at NIS 34.185 million and Jabotinsky at NIS 37.042 million. Together they account for NIS 71.227 million, roughly 64% of the total project-pipeline excess value. The remaining roughly NIS 39.5 million, about 36% of the total, sits in projects measured at 70% or 50% certainty. Uriya Hachiti B appears with zero excess value because it is still only at the developer-selection stage without the required majority.

This is not an accounting error. It simply means the balance sheet received value today that still depends on planning progress and execution tomorrow. The gap between accounting value and realized value did not disappear. It just moved from "is there a pipeline?" to "how much of the pipeline is genuinely mature enough to convert?"

Related-Party Debt Also Added Accounting Upside

The PPA did not enlarge the balance sheet only through projects. It also remeasured the Abu-related obligation. Under note 16, Gefen and the acquired company are supposed to repay combined obligations of roughly NIS 38.9 million to Abu within two years, in eight quarterly principal instalments of NIS 5 million plus interest under section 3(i) of the Income Tax Ordinance. The PPA breaks it out precisely: a nominal obligation of NIS 38.993 million, a fair value of NIS 37.161 million, and NIS 1.832 million of excess value, with a NIS 421 thousand deferred-tax reserve alongside it.

Again, the message matters more than the isolated number. That NIS 1.832 million difference did not come from development execution. It came from discounting a related-party liability using an estimated 9.50% debt cost and a duration of 1.12. In plain language, part of the balance-sheet improvement is simply the present-value remeasurement of a financing obligation.

And there is another layer of caution here. Note 16 gives the audit committee authority to defer a quarterly payment, in whole or in part, if paying it could hurt the operating budget, investment needs, financial covenants or the company's ability to meet obligations. Management also approached the audit committee with a request to defer all payments due to Abu until March 2028, subject to quarterly review. That is a very important point: even the payment mechanism itself signals that the path from accounting value to cash value is not yet fully settled.

The Auditors Flagged Exactly The Two Areas That Matter

Anyone looking for an external warning label gets it in the audit report. The auditors identified two key audit matters: costs capitalized into inventory, and business combinations under common control. That is not a side note. Those are exactly the two accounting zones that gave 2025 its new shape.

On the first matter, the auditor points to inventory of NIS 227.59 million and says capitalization depends on planning status, financing and signature levels versus the required threshold. On the second, the auditor explains that the allocation of purchase consideration, recognition of goodwill and identification of excess value in the Abu transaction involved a high degree of judgment, so the team tested base assumptions, discount rates, methodology, completeness of assets and liabilities, and consistency with signed agreements.

This does not mean the numbers are wrong. It means the areas where the balance sheet moved the most are also the areas with the heaviest accounting judgment. So anyone reading Gefen after the transaction has to hold two ideas at the same time: the deal truly enlarged the asset base, but a meaningful part of that base still depends on assumptions that must clear a real-world execution test.

Bottom Line

The Abu transaction changed Gefen's balance-sheet scale sharply and immediately. But anyone reading that jump as if it mostly came from execution already proven in the field is reading too fast. A large part of it was built through purchase-price allocation: NIS 14.19 million of fair-valued non-controlling interests, NIS 110.762 million of discounted project-pipeline excess value, NIS 1.832 million of excess value from discounting owner debt, and only then NIS 6.509 million of goodwill.

That defines the follow-through test. If Pladot and Jabotinsky advance quickly, if the projects measured at 70% and 50% certainty move up the ladder, and if Abu-group debt repayment converges without stressing the company, today's PPA could later look relatively conservative. If not, part of the balance-sheet jump will remain economically earlier than it is operationally. That is why, for a residential developer, the key question is not just how much value entered the balance sheet, but how much of that value is truly reachable for shareholders after permits, financing, execution and tax.